FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds of formula (I)
or pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and to methods of producing said compounds.
EFFECT: novel compounds which can be used in treating conditions or diseases mediated by the P2X7 receptor are obtained.
15 cl, 1 dwg, 2 tbl, 251 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
| NEW BICYCLIC COMPOUNDS OF THIOPHENYLAMIDE | 2013 |
|
RU2644565C2 |
| PHENOXYMETHYL DERIVATIVES | 2016 |
|
RU2746481C1 |
| SUBSTITUTED THIOPHENECARBOXAMIDES AND DERIVATIVES THEREOF | 2020 |
|
RU2834236C2 |
| HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
| THIENYLOXAZOLONES AND ANALOGUES | 2020 |
|
RU2831013C1 |
| NOVEL HETEROARYLTRIAZOLE COMPOUNDS AS PESTICIDES | 2020 |
|
RU2824488C2 |
| OXADIAZOLONE DERIVATIVES AS PPAR-DELTA AGONISTS | 2005 |
|
RU2374243C2 |
| SUBSTITUTED THIOPHENECARBOXAMIDES AND DERIVATIVES THEREOF AS MICROBIOCIDES | 2020 |
|
RU2832576C1 |
| SUBSTITUTED THIOPHENECARBOXAMIDES AND DERIVATIVES THEREOF | 2020 |
|
RU2837213C1 |
Authors
Dates
2022-03-25—Published
2018-05-02—Filed